Evidence-Based Complementary and Alternative Medicine

Application of Complementary and Alternative Medicine on Neurodegenerative Disorders 2013


Publishing date
01 Nov 2013
Status
Published
Submission deadline
14 Jun 2013

Lead Editor

1School of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong

2Division of Life Science, The Hong Kong University of Science and Technology, Hong Kong

3Faculty of Pharmacy, The University of Sydney, Sydney, NSW, Australia; Centre for Complementary Medicine Research, University of Western Sydney, Sydney, NSW, Australia

4Department of Pharmacognosy, Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria


Application of Complementary and Alternative Medicine on Neurodegenerative Disorders 2013

Description

Neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis, and depression are prevalent and devastating illnesses. The World Health Organization estimates that, by 2040, neurodegenerative diseases will surpass cancer as the principal cause of death in industrialized countries. Neurodegenerative disorders are characterized by progressive loss of neurons in sensory, motor, and cognitive systems. Despite various advances in the understanding of the diseases, pharmacological treatment by conventional medicine has not obtained satisfactory results. However, recent studies suggest that complementary and alternative medicine (CAM) is a potential candidate for the preventative treatment of the disorders.

Therefore, we invite investigators to contribute original research articles as well as review articles that provide solid evidence to support the application of CAM in prevention and treatment of neurodegenerative disorders. We are particularly interested in articles reporting randomized, double-blind, and placebo-controlled trials or revealing the action mechanisms of CAM by using cellular or animal models. Potential topics include, but are not limited to:

  • Clinical trials of CAM on prophylactic and/or therapeutic treatments of neurodegenerative disorders
  • Recent applications of CAM in prevention and treatment of neurodegenerative disorders by using cellular or animal models
  • Advances in revealing acting targets of CAM in treating neurodegenerative disorders
  • Advances in identifying active ingredients of medicinal herbs against neurodegenerative disorders
  • Synergistic acting mechanisms among chemical ingredients of medicine herbs
  • Optimization of multiherb prescriptions in treating neurodegenerative disorders
  • Current and prospective strategies of CAM for combating neurodegenerative disorders

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at http://www.hindawi.com/journals/ecam/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/ecam/camnd13/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2014
  • - Article ID 463929
  • - Editorial

Application of Complementary and Alternative Medicine on Neurodegenerative Disorders 2013

Paul Siu-Po Ip | Karl Wah-Keung Tsim | ... | Rudolf Bauer
  • Special Issue
  • - Volume 2013
  • - Article ID 163057
  • - Research Article

Isorhynchophylline Protects PC12 Cells Against Beta-Amyloid-Induced Apoptosis via PI3K/Akt Signaling Pathway

Yan-Fang Xian | Zhi-Xiu Lin | ... | Paul Siu-Po Ip
  • Special Issue
  • - Volume 2013
  • - Article ID 937370
  • - Research Article

Acetylshikonin, a Novel AChE Inhibitor, Inhibits Apoptosis via Upregulation of Heme Oxygenase-1 Expression in SH-SY5Y Cells

Yan Wang | Wen-Liang Pan | ... | David Chi-Cheong Wan
  • Special Issue
  • - Volume 2013
  • - Article ID 731385
  • - Research Article

Kai-Xin-San, a Chinese Herbal Decoction Containing Ginseng Radix et Rhizoma, Polygalae Radix, Acori Tatarinowii Rhizoma, and Poria, Stimulates the Expression and Secretion of Neurotrophic Factors in Cultured Astrocytes

Kevin Yue Zhu | Sherry Li Xu | ... | Karl Wah-Keung Tsim
  • Special Issue
  • - Volume 2013
  • - Article ID 687958
  • - Research Article

Song Bu Li Decoction, a Traditional Uyghur Medicine, Protects Cell Death by Regulation of Oxidative Stress and Differentiation in Cultured PC12 Cells

Maitinuer Maiwulanjiang | Kevin Y. Zhu | ... | Karl W. K. Tsim
  • Special Issue
  • - Volume 2013
  • - Article ID 516741
  • - Research Article

The Aqueous Extract of Rhizome of Gastrodia elata Protected Drosophila and PC12 Cells against Beta-Amyloid-Induced Neurotoxicity

Chun-Fai Ng | Chun-Hay Ko | ... | Clara Bik-San Lau
  • Special Issue
  • - Volume 2013
  • - Article ID 971712
  • - Research Article

P90RSK and Nrf2 Activation via MEK1/2-ERK1/2 Pathways Mediated by Notoginsenoside R2 to Prevent 6-Hydroxydopamine-Induced Apoptotic Death in SH-SY5Y Cells

Xiang-Bao Meng | Gui-Bo Sun | ... | Xiao-Bo Sun
  • Special Issue
  • - Volume 2013
  • - Article ID 347525
  • - Research Article

Open Randomized Clinical Trial on JWSJZ Decoction for the Treatment of ALS Patients

Weidong Pan | Xiaojing Su | ... | Hua Zhou
  • Special Issue
  • - Volume 2013
  • - Article ID 957875
  • - Review Article

Advances in Neuroprotective Ingredients of Medicinal Herbs by Using Cellular and Animal Models of Parkinson’s Disease

Sandeep Vasant More | Hemant Kumar | ... | Dong-Kug Choi
  • Special Issue
  • - Volume 2013
  • - Article ID 127075
  • - Research Article

Flavonoids Induce the Synthesis and Secretion of Neurotrophic Factors in Cultured Rat Astrocytes: A Signaling Response Mediated by Estrogen Receptor

Sherry L. Xu | Cathy W. C. Bi | ... | Karl W. K. Tsim
Evidence-Based Complementary and Alternative Medicine
 Journal metrics
Acceptance rate28%
Submission to final decision80 days
Acceptance to publication46 days
CiteScore2.010
Impact Factor1.984
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.